AMEX

iShares LifePath Target Date 2050 ETF (ITDF)

533 Thanks from members

The iShares LifePath Target Date 2050 ETF (ITDF) exhibits moderate market sentiment, backed by a Morningstar Gold rating, low 0.11% expense ratio, and upcoming June 2026 asset allocation shifts toward higher equity exposure.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →